Disposition of gamma-hydroxybutyric acid in conventional and nonconventional biologic fluids after single drug administration: Issues in methodology and drug monitoring

Therapeutic Drug Monitoring

Volumn 29, Issue 1, 2007, Pages 64-70

  Abanades, Sergio ^a,c   Farré, Magi ^a,c   Segura, Mireia ^a,d   Pichini, Simona ^b   Pastor, Antoni ^a   Pacifici, Roberta ^b   Pellegrini, Manuela ^b   Torre, Rafael De La ^a,d  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

GHB; Oral fluid; Plasma; Subjective effects; Sweat

Indexed keywords

OXYBATE SODIUM;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY FLUID; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG EXCRETION; DRUG HALF LIFE; DRUG MONITORING; DRUG STABILITY; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; METHODOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; SWEAT; TANDEM MASS SPECTROMETRY; URINALYSIS; URINARY EXCRETION; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; DRUG MONITORING; DRUG STABILITY; HALF-LIFE; HUMANS; HYDROXYBUTYRATES; MALE; REPRODUCIBILITY OF RESULTS; SALIVA; SWEAT; TEMPERATURE; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 33847126261     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3180307e5e     Document Type: Article

References (36)

1. Nicholson KL, Balster RL. GHB: a new and novel drug of abuse. Drug Alcohol Depend. 2001;63:1-22.
2. Chin RL, Sporer KA, Cullison B, et al. Clinical course of gamma-hydroxybutyrate overdose. Ann Emerg Med. 1998;31:716-722.
3. Palatini P, Tedeschi L, Frison G, et al. Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur J Clin Pharmacol. 1993;45:353-356.
4. Ferrara SD, Zotti S, Tedeschi L, et al. Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br J Clin Pharmacol. 1992;34:231-235.
5. McCusker RR, Paget-Wilkes H, Chronister CW, et al. Analysis of gamma-hydroxybutyrate (GHB) in urine by gas chromatography-mass spectrometry. J Anal Toxicol. 1999;23:301-305.
6. LeBeau MA, Montgomery MA, Miller ML, et al. Analysis of biofluids for gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) by headspace GC-FID and GC-MS. J Anal Toxicol. 2000;24:421-428.
7. Couper FJ, Logan BK. Determination of gamma-hydroxybutyrate (GHB) in biological specimens by gas chromatography-mass spectrometry. J Anal Toxicol. 2000;24:1-7.
8. Frison G, Tedeschi L, Maietti S, et al. Determination of gamma-hydroxybutyric acid (GHB) in plasma and urine by headspace solid-phase microextraction and gas chromatography/positive ion chemical ionization mass spectrometry. Rapid Commun Mass Spectrom. 2000;14:2401-2407.
9. Elian AA. A novel method for GHB detection in urine and its application in drug-facilitated sexual assaults. Forensic Sci Int. 2000;109:183-187.
10. de Vriendt CA, van Sassenbroeck DK, Rosseel MT, et al. Development and validation of a high-performance liquid chromatographic method for the determination of gamma-hydroxybutyric acid in rat plasma. J Chromatogr B Biomed Sci Appl. 2001;752:85-90.
11. Chen M, Andrenyak DM, Moody DE, et al. Stability of plasma gamma-hydroxybutyrate determined by gas chromatography-positive ion chemical ionization-mass spectrometry. J Anal Toxicol. 2003;27:445-448.
12. Villain M, Cirimele V, Ludes B, et al. Ultra-rapid procedure to test for gamma-hydroxybutyric acid in blood and urine by gas chromatographymass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;792:83-87.
13. Kintz P, Cirimele V, Jamey C, et al. Testing for GHB in hair by GC/MS/MS after a single exposure. Application to document sexual assault. J Forensic Sci. 2003;48:195-200.
14. Verstraete AG. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit. 2004;26:200-205.
15. Elian AA. Determination of endogenous gamma-hydroxybutyric acid (GHB) levels in antemortem urine and blood. Forensic Sci Int. 2002;128:120-122.
16. LeBeau MA, Montgomery MA, Morris-Kukoski C, et al. A comprehensive study on the variations in urinary concentrations of endogenous gamma-hydroxybutyrate (GHB). J Anal Toxicol. 2006;30:98-105.
17. Tedeschi L, Carai MA, Frison G, et al. Endogenous gamma-hydroxybutyric acid is in the rat, mouse and human gastrointestinal tract. Life Sci. 2003;72:2481-2488.
18. Yeatman DT, Reid K. A study of urinary endogenous gamma-hydroxybutyrate (GHB) levels. J Anal Toxicol. 2003;27:40-42.
19. Elliott SP. Gamma hydroxybutyric acid (GHB) concentrations in humans and factors affecting endogenous production. Forensic Sci Int. 2003;133:9-16.
20. Kerrigan S. In vitro production of gamma-hydroxybutyrate in antemortem urine samples. J Anal Toxicol. 2002;26:571-574.
21. Sakurada K, Kobayashi M, Iwase H, et al. Production of gamma-hydroxybutyric acid in postmortem liver increases with time after death. Toxicol Lett. 2002;129:207-217.
22. Elliott S, Lowe P, Symonds A. The possible influence of micro-organisms and putrefaction in the production of GHB in post-mortem biological fluid. Forensic Sci Int. 2004;139:183-190.
23. Wong CG, Gibson KM, Snead OC 3rd. From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends Pharmacol Sci. 2004;25:29-34.
24. Elliot S. The presence of gamma-hydroxybutyric acid (GHB) in postmortem biological fluids. J Anal Toxicol. 2001;25:152.
25. Kintz P, Goulle JP, Cirimele V, et al. Window of detection of gamma-hydroxybutyrate in blood and saliva. Clin Chem. 2001;47:2033-2034.
26. Caputo F, Addolorato G, Lorenzini F, et al. Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study. Drug Alcohol Depend. 2003;70:85-91.
27. Brenneisen R, Elsohly MA, Murphy TP, et al. Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects. J Anal Toxicol. 2004;28:625-630.
28. Abanades S, Farré M, Segura M, et al. Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics. Ann N Y Acad Sci. 2006;1074:559-576.
29. Krouwer JS, Rabinowitz R. How to improve estimates of imprecision. Clin Chem. 1984;30:290-292.
30. Guidance for Industry, Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration; May 2001 Available at: www.fda.gov/cder/guidance/4252fnl.htm.
31. The European Agency for the evaluation of Medicinal Products: ICH Topic Q 2 B Validation of Analytical Procedures: Methodology. Available at: www.emea.eu.int/htms/human/ich/quality/ichfin.htm.
32. Sporer KA, Chin RL, Dyer JE, et al. Gamma-hydroxybutyrate serum levels and clinical syndrome after severe overdose. Ann Emerg Med. 2003;42:3-8.
33. Navarro M, Pichini S, Farre M, et al. Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH. Clin Chem. 2001;47:1788-1795.
34. Kavanagh PV, Kenny P, Feely J. The urinary excretion of gamma-hydroxybutyric acid in man. J Pharm Pharmacol. 2001;53:399-402.
35. Davidson D, Hutchison K, Dagon C, et al. Assessing the stimulant effects of alcohol in humans. Pharmacol Biochem Behav. 2002;72:151-156.
36. Heishman SJ, Arasteh K, Stitzer ML. Comparative effects of alcohol and marijuana on mood, memory, and performance. Pharmacol Biochem Behav. 1997;58:93-101.